Literature DB >> 9893729

Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.

M O Gray1, C S Long, J E Kalinyak, H T Li, J S Karliner.   

Abstract

OBJECTIVE: We sought to determine whether angiotensin II (Ang II) promotes hypertrophy of cardiac directly or via paracrine mechanisms mediated by cardiac fibroblasts.
METHODS: We studied neonatal rat cardiac myocytes and fibroblasts in culture as a model system. Paracrine effects of Ang II were identified using conditioned medium and co-culture experiments.
RESULTS: Ang II type 1 (AT1) receptors responsible for myocyte growth localized to fibroblasts in radioligand binding, emulsion autoradiography, Western analysis, and immunofluorescence staining experiments. The bulk of AT1 receptor binding in myocyte cultures (1343 +/- 472 sites/cell) was to Ang II receptors on contaminating fibroblasts (9747 +/- 2126 sites/cell). Ang II induced significant paracrine trophic effects on myocytes in conditioned medium (40% increase in protein synthesis over control) and co-culture (4-fold increase over control) experiments. TGF-beta 1 and endothelin-1 were paracrine mediators of hypertrophy in neutralization experiments.
CONCLUSIONS: Ang II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from cardiac fibroblasts in a neonatal rat cell culture model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893729     DOI: 10.1016/s0008-6363(98)00121-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  125 in total

Review 1.  Transforming growth factor beta-angiotensin II interaction: implications for cardiac and renal disease.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  1999-07       Impact factor: 4.599

2.  Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.

Authors:  Michael D Schneider
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study.

Authors:  S Busche; S Gallinat; R M Bohle; A Reinecke; J Seebeck; F Franke; L Fink; M Zhu; C Sumners; T Unger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 4.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

5.  Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts.

Authors:  C Ruwhof; A E van Wamel; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 6.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 7.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 8.  The role of P2X7 receptors in tissue fibrosis: a brief review.

Authors:  Daniela Gentile; Mariarita Natale; Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Purinergic Signal       Date:  2015-08-29       Impact factor: 3.765

9.  Altered expression of angiotensin II receptor subtypes and transforming growth factor-beta in the heart of nitrofen-induced diaphragmatic hernia in rats.

Authors:  Honami Teramoto; Masato Shinkai; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-12-02       Impact factor: 1.827

Review 10.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.